Xtressé, a company focused on hair and scalp therapy, has officially launched, supported by a team of dermatologists and hair restoration experts with over 180 years of combined experience. The company aims to address the hair health industry by providing scientifically-backed solutions for hair thinning and loss.
The founders of Xtressé identified a significant gap in the market, noting that over 80 million Americans experience some form of hair thinning or loss. They argue that many existing solutions are inadequate, as they often only provide superficial benefits or rely on outdated scientific principles. Xtressé intends to change this by offering a range of expert-formulated products that utilize modern formulations and proprietary X3 Technologies to promote scalp health and support hair growth.
The initial product introduced by Xtressé is the Hair Growth Gummies, which are designed to encourage healthy hair growth at a cellular level without the use of biotin. These sugar-free gummies serve as a daily supplement that aims to enhance the body’s natural capacity for hair growth by addressing factors such as inflammation, oxidative stress, and hormonal imbalances. The gummies incorporate the company’s proprietary X3 Technologies, which have been in development for over two years. Each blend combines various ingredients that work together to improve scalp health and stimulate hair growth. Key components include NAD+, Pumpkin Seed Extract, Taurine, Saw Palmetto, and essential vitamins and minerals.
Dr. Matt Leavitt, a dermatologist and co-founder of Xtressé, highlighted the limitations of traditional treatments, many of which rely on biotin, an ingredient he claims lacks proven effectiveness. He emphasized the need for a more advanced solution, which led to the development of X3 Technologies that target the underlying causes of hair thinning at the cellular level.
In addition to the Hair Growth Gummies, Xtressé plans to expand its product line later in the year to include a comprehensive range of treatments that will feature the X3-BioActive Blend and a patent-pending X3-Peptide Complex, which consists of bioactive peptides known for their regenerative properties.